Clinical utility of serum HER2/neu in monitoring and prediction of progression-free survival in metastatic breast cancer patients treated with trastuzumab-based therapies (Q24810552)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Clinical utility of serum HER2/neu in monitoring and prediction of progression-free survival in metastatic breast cancer patients treated with trastuzumab-based therapies |
scientific article |
Statements
1 reference
Clinical utility of serum HER2/neu in monitoring and prediction of progression-free survival in metastatic breast cancer patients treated with trastuzumab-based therapies (English)
1 reference
Francisco J Esteva
1 reference
Carol D Cheli
1 reference
Herbert Fritsche
1 reference
Monica Fornier
1 reference
Dennis Slamon
1 reference
Robert P Thiel
1 reference
Diana Luftner
1 reference
Farooq Ghani
1 reference
8 April 2005
1 reference
1 reference
R436-43
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference